Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia

Schizophrenia is a complex psychiatric disorder strongly associated with substance use disorders. Theoretically, schizophrenia and SUD may share endocannabinoid alterations in the brain reward system. The main endocannabinoids, anandamide, and 2-arachidonoylglycerol, are lipids which bind cannabinoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Desfossés, Joëlle, Stip, Emmanuel, Bentaleb, Lahcen Ait, Lipp, Olivier, Chiasson, Jean-Pierre, Furtos, Alexandra, Venne, Karine, Kouassi, Edouard, Potvin, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
https://www.ncbi.nlm.nih.gov/pubmed/23055987
http://dx.doi.org/10.3389/fpsyt.2012.00085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
https://www.ncbi.nlm.nih.gov/pubmed/23055987
http://dx.doi.org/10.3389/fpsyt.2012.00085

Ejemplares similares